Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
LifeTech Scientific Corporation ( (HK:1302) ) has shared an update.
LifeTech Scientific Corporation has scheduled a board meeting for 31 March 2026 to review and approve the audited annual results for the year ended 31 December 2025 and to authorize their release on the company’s and the Hong Kong exchange’s websites. The board will also consider whether to recommend a final dividend, potential closure of the register of members, and arrangements for the forthcoming annual general meeting, signaling routine governance steps that may shape shareholder returns and upcoming corporate actions.
The most recent analyst rating on (HK:1302) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on LifeTech Scientific Corporation stock, see the HK:1302 Stock Forecast page.
More about LifeTech Scientific Corporation
LifeTech Scientific Corporation is a Cayman Islands–incorporated medical technology company listed in Hong Kong under stock code 1302. The group operates through various subsidiaries and is overseen by a board that includes executive, non-executive and independent non-executive directors, reflecting a standard listed-company governance structure and focus on regulated capital market disclosure.
Average Trading Volume: 18,980,082
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.69B
Learn more about 1302 stock on TipRanks’ Stock Analysis page.